Ramsay Health Care : ASX Announcement - ASX Appendix 3Y Change of Director's Interest Notice – C McNally
RHC.AX
Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
Ramsay Health Care Limited
ABN
57 001 288 768
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director
Craig Ralph McNally
Date of last notice
15 December 2020
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest
Direct interest - see below
Indirect interest - no change
Nature of indirect interest
N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
31 August 2021
Appendix 3Y
Change of Director's Interest Notice
No. of securities held prior to change
Direct interest
305,549 ordinary shares
16,158 restricted ordinary shares held
pursuant to the terms of Mr McNally's
FY2018 and FY2019 short term
incentive awards
140,808
Performance
Rights
granted
under the terms of the Ramsay
Executive Performance Rights Plan,
but not yet vested
55,563
Performance
Rights
granted
under the terms of the Ramsay Equity
Incentive Plan, but not yet vested
Indirect interest
30,000 ordinary shares held through L
& C McNally Pty Ltd (McNally Family
A/c)
Class
Performance rights granted under the
Ramsay Equity Incentive Plan
Number acquired
-
Number disposed
90,325 Performance Rights granted under
the Executive Performance Rights Plan
failed to vest and therefore lapsed on
31 August 2021.
Value/Consideration
Nil
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change
Direct interest
305,549 ordinary shares
16,158 restricted ordinary shares held
pursuant to the terms of Mr McNally's
FY2018 and FY2019 short term
incentive awards
50,483
Performance
Rights
granted
under the terms of the Ramsay
Executive Performance Rights Plan,
but not yet vested
55,563
Performance
Rights
granted
under the terms of the Ramsay Equity
Incentive Plan, but not yet vested
Indirect interest
30,000 ordinary shares held through L
& C McNally Pty Ltd (McNally Family
A/c)
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director's Interest Notice
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
LTI Performance Rights granted under the Ramsay Executive Performance Rights Plan which failed to achieve the various performance conditions required for vesting and therefore lapse on 31 August 2021 in accordance with the terms of issue.
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
N/A
(if issued securities)
Date of change
N/A
No. and class of securities to which
N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
Part 3 - +Closed period
Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade N/A to proceed during this period?
If prior written clearance was provided, on what date was this N/A provided?
Disclaimer
Ramsay Health Care Limited published this content on 03 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 September 2021 06:51:02 UTC.